Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: A pilot study

Clinical Research in Cardiology

Volumn 100, Issue 10, 2011, Pages 887-896

  Nia, Amir M ^a   Gassanov, Natig ^a   Dahlem, Kristina M ^a   Caglayan, Evren ^a   Hellmich, Martin ^a   Erdmann, Erland ^a   Er, Fikret ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Heart failure; NT proBNP; Tachyarrhythmia; Tachycardia mediated cardiomyopathy

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MAJOR STRUCTURAL HEART DISEASE; MALE; OUTCOME ASSESSMENT; SENSITIVITY AND SPECIFICITY; TACHYCARDIA MEDIATED CARDIOMYOPATHY;

AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; ELECTRIC COUNTERSHOCK; EXERCISE TEST; FEMALE; GERMANY; HEART CATHETERIZATION; HEART FAILURE; HEART RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; ROC CURVE; STROKE VOLUME; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 80054736092     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0319-y     Document Type: Article

References (36)

1. M Brignole L Gianfranchi C Menozzi N Bottoni R Bollini G Lolli D Oddone G Gaggioli 1994 Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance Am J Cardiol 74 3 242 246 0002-9149(94)90364-6[pii] 8037128 10.1016/0002-9149(94)90364-6 1:STN:280:DyaK2czhtFahsg%3D%3D (Pubitemid 24239045)
2. M Grogan HC Smith BJ Gersh DL Wood 1992 Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy Am J Cardiol 69 19 1570 1573 1598871 10.1016/0002-9149(92)90705- 4 1:STN:280:DyaK383os1agtw%3D%3D
3. CA Rinaldi DS Thompson 1999 Tachycardia-induced cardiomyopathy caused by atrial flutter responding to DC cardioversion Hosp Med 60 4 305 306 10396442 1:STN:280:DyaK1MzisVOltg%3D%3D
4. FE Cruz EC Cheriex JL Smeets J Atie AK Peres OC Penn P Brugada HJ Wellens 1990 Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia J Am Coll Cardiol 16 3 739 744 0735-1097(90)90368-Y[pii] 2387945 10.1016/0735-1097(90)90368-Y 1:STN:280:DyaK3czlsVGrtg%3D%3D (Pubitemid 20296141)
5. J Vijgen P Hill LA Biblo MD Carlson 1997 Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia J Cardiovasc Electrophysiol 8 4 445 450 9106431 10.1111/j.1540-8167.1997.tb00811.x 1:STN:280: DyaK2s3mtVeisw%3D%3D (Pubitemid 27172169)
6. A Link JC Reil S Selejan M Bohm 2009 Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure Clin Res Cardiol 98 8 513 515 10.1007/s00392-009-0038-9 19547907 10.1007/s00392-009-0038-9
7. JR Wilson P Douglas WF Hickey V Lanoce N Ferraro A Muhammad N Reichek 1987 Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects Circulation 75 4 857 867 3829344 10.1161/01.CIR.75.4.857 1:STN:280:DyaL2s7lvF2gtA%3D%3D (Pubitemid 17052671)
8. FG Spinale HH Holzgrefe R Mukherjee SR Arthur MJ Child JR Powell WH Koster 1995 LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy Am J Physiol 268 2 Pt 2 H836 H847 7864211 1:CAS:528:DyaK2MXktFamsr4%3D
9. JS Shinbane MA Wood DN Jensen KA Ellenbogen AP Fitzpatrick MM Scheinman 1997 Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 4 709 715 S073510979600592X[pii] 9091514 10.1016/S0735-1097(96)00592-X 1:STN:280:DyaK2s3is1ersA%3D%3D (Pubitemid 27128241)
10. K Yamamoto JC Burnett Jr LM Meyer L Sinclair TL Stevens MM Redfield 1996 Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model Am J Physiol 271 6 Pt 2 R1529 R1534 8997349 1:CAS:528:DyaK2sXmt1CjsA%3D%3D
11. R Mukherjee KW Hewett FG Spinale 1995 Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy J Mol Cell Cardiol 27 6 1333 1348 S0022-2828(05)82396-X[pii] 8531216 10.1016/S0022-2828(05)82396-X 1:CAS:528:DyaK2MXms1ertLk%3D
12. WS McMahon R Mukherjee PC Gillette FA Crawford FG Spinale 1996 Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and beta-adrenergic responsiveness Cardiovasc Res 31 2 314 323 0008-6363(95)00212-X[pii] 8730409 1:STN:280:DyaK283ps12mtA%3D%3D (Pubitemid 26089966)
13. AM Nia E Caglayan N Gassanov T Zimmermann O Aslan M Hellmich F Duru E Erdmann S Rosenkranz F Er 2010 Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation PLoS One 5 7 e11421 10.1371/journal.pone.0011421 20625396 10.1371/journal.pone.0011421
14. F Er O Aslan E Caglayan N Gassanov AM Nia E Erdmann S Rosenkranz 2010 Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study Clin Res Cardiol 99 6 369 373 10.1007/s00392-010-0129-7 20180126 10.1007/s00392-010-0129- 7 1:CAS:528:DC%2BC3cXmsFSlt7Y%3D
15. KP Letsas GS Filippatos LK Pappas CC Mihas V Markou IP Alexanian M Efremidis A Sideris AS Maisel F Kardaras 2009 Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction Clin Res Cardiol 98 2 101 106 10.1007/s00392-008-0728-8 18975023 10.1007/s00392-008-0728-8 1:CAS:528:DC%2BD1MXhvF2msr8%3D
16. JP Steinhoff RG Sheahan 2005 Tachycardia-induced cardiomyopathy: atrial fibrillation and congestive heart failure Am J Med Sci 329 1 25 28 00000441-200501000-00006[pii] 15654177 10.1097/00000441-200501000-00006 (Pubitemid 40096802)
17. Dickstein K (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Reply. Eur Heart J. doi: 10.1093/eurheartj/ehn561
18. N Nagaya T Nishikimi Y Okano M Uematsu T Satoh S Kyotani S Kuribayashi S Hamada M Kakishita N Nakanishi M Takamiya T Kunieda H Matsuo K Kangawa 1998 Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension J Am Coll Cardiol 31 1 202 208 S0735-1097(97)00452-X[pii] 9426041 10.1016/S0735-1097(97)00452-X 1:STN:280:DyaK1c%2Fos1Sisg%3D%3D (Pubitemid 28064743)
19. M Weber R Arnold M Rau A Elsaesser R Brandt V Mitrovic C Hamm 2005 Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease Eur Heart J 26 10 1023 1030 10.1093/eurheartj/ehi236 15781428 10.1093/eurheartj/ehi236 1:CAS:528:DC%2BD2MXltlOitr8%3D (Pubitemid 40695033)
20. Z Golbasy O Ucar AG Yuksel O Gulel S Aydogdu V Ulusoy 2004 Plasma brain natriuretic peptide levels in patients with rheumatic heart disease Eur J Heart Fail 6 6 757 760 10.1016/j.ejheart.2004.04.018 15542413 10.1016/j.ejheart.2004. 04.018 (Pubitemid 39470231)
21. H Yamaguchi J Yoshida K Yamamoto Y Sakata T Mano N Akehi M Hori YJ Lim M Mishima T Masuyama 2004 Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy J Am Coll Cardiol 43 1 55 60 S0735109703013718[pii] 14715184 10.1016/j.jacc.2003.07. 037 1:CAS:528:DC%2BD2cXht1ehsrg%3D (Pubitemid 38045916)
22. H Silvet Y Young-Xu D Walleigh S Ravid 2003 Brain natriuretic peptide is elevated in outpatients with atrial fibrillation Am J Cardiol 92 9 1124 1127 S0002914903010531[pii] 14583372 10.1016/j.amjcard.2003.07.010 1:CAS:528:DC%2BD3sXosVyltbo%3D (Pubitemid 37329544)
23. T Simon R Becker F Voss O Bikou M Hauck M Licka HA Katus A Bauer 2008 Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events Clin Res Cardiol 97 5 306 309 10.1007/s00392-007-0629-2 18193374 10.1007/s00392-007-0629-2 1:CAS:528:DC%2BD1cXmvVCltb0%3D (Pubitemid 351725056)
24. PM Bossuyt JB Reitsma DE Bruns CA Gatsonis PP Glasziou LM Irwig D Moher D Rennie HC de Vet JG Lijmer 2003 The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration Ann Intern Med 138 1 W1 W12 200301070-00012-W1[pii] 12513067
25. RM Lang M Bierig RB Devereux FA Flachskampf E Foster PA Pellikka MH Picard MJ Roman J Seward JS Shanewise SD Solomon KT Spencer MS Sutton WJ Stewart 2005 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 12 1440 1463 10.1016/j.echo.2005.10.005 16376782 10.1016/j.echo.2005.10.005 (Pubitemid 41821197)
26. MA Quinones CM Otto M Stoddard A Waggoner WA Zoghbi 2002 Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 2 167 184 S089473170245599X[pii] 11836492 10.1067/mje.2002.120202
27. CL Wang KH Lin N Luqman PH Chu LA Hsu CT Kuo 2004 Simultaneous biplane single-beat assessment of left ventricular systolic function in patients with atrial fibrillation Am J Cardiol 94 7 942 944 10.1016/j.amjcard.2004.06.035 15464684 10.1016/j.amjcard.2004.06.035 (Pubitemid 39349564)
28. D Daneshvar J Wei K Tolstrup LE Thomson C Shufelt CN Merz 2010 Diastolic dysfunction: improved understanding using emerging imaging techniques Am Heart J 160 3 394 404 10.1016/j.ahj.2010.06.040 20826245 10.1016/j.ahj.2010.06.040
29. SF Nagueh CP Appleton TC Gillebert PN Marino JK Oh OA Smiseth AD Waggoner FA Flachskampf PA Pellikka A Evangelisa AS Echocardiography 2009 Recommendations for the evaluation of left ventricular diastolic function by echocardiography Eur J Echocardiogr 10 2 165 193 0.1093/ejechocard/jep007 19270053 10.1093/ejechocard/jep007
30. C Medi JM Kalman H Haqqani JK Vohra JB Morton PB Sparks PM Kistler 2009 Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation J Am Coll Cardiol 53 19 1791 1797 10.1016/j.jacc.2009.02.014 19422986 10.1016/j.jacc.2009.02.014
31. DG Wyse AL Waldo JP DiMarco MJ Domanski Y Rosenberg EB Schron JC Kellen HL Greene MC Mickel JE Dalquist SD Corley 2002 A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 23 1825 1833 10.1056/NEJMoa021328 12466506 10.1056/NEJMoa021328 1:STN:280: DC%2BD38jgslKgug%3D%3D (Pubitemid 35417773)
32. IC Van Gelder VE Hagens HA Bosker JH Kingma O Kamp T Kingma SA Said JI Darmanata AJ Timmermans JG Tijssen HJ Crijns 2002 A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 23 1834 1840 10.1056/NEJMoa021375 12466507 10.1056/NEJMoa021375 (Pubitemid 35417774)
33. D Roy M Talajic S Nattel DG Wyse P Dorian KL Lee MG Bourassa JM Arnold AE Buxton AJ Camm SJ Connolly M Dubuc A Ducharme PG Guerra SH Hohnloser J Lambert JY Le Heuzey G O'Hara OD Pedersen JL Rouleau BN Singh LW Stevenson WG Stevenson B Thibault AL Waldo 2008 Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 25 2667 2677 10.1056/NEJMoa0708789 18565859 10.1056/NEJMoa0708789 1:CAS:528: DC%2BD1cXns1Wrtr0%3D (Pubitemid 351860859)
34. IC Van Gelder HF Groenveld HJ Crijns YS Tuininga JG Tijssen AM Alings HL Hillege JA Bergsma-Kadijk JH Cornel O Kamp R Tukkie HA Bosker DJ Van Veldhuisen MP Van den Berg 2010 Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 15 1363 1373 10.1056/NEJMoa1001337 20231232 10.1056/NEJMoa1001337
35. K Dickstein A Cohen-Solal G Filippatos JJ McMurray P Ponikowski PA Poole-Wilson A Stromberg DJ van Veldhuisen D Atar AW Hoes A Keren A Mebazaa M Nieminen SG Priori K Swedberg A Vahanian J Camm R De Caterina V Dean C Funck-Brentano I Hellemans SD Kristensen K McGregor U Sechtem S Silber M Tendera P Widimsky JL Zamorano 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 19 2388 2442 10.1093/eurheartj/ehn309 18799522 10.1093/eurheartj/ehn309 1:CAS:528:DC%2BD1cXhtlGisbvO
36. M Jessup WT Abraham DE Casey AM Feldman GS Francis TG Ganiats MA Konstam DM Mancini PS Rahko MA Silver LW Stevenson CW Yancy 2009 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the international society for heart and lung transplantation Circulation 119 14 1977 2016 10.1161/CIRCULATIONAHA.109.192064 19324967 10.1161/CIRCULATIONAHA.109. 192064